| Year |
Citation |
Score |
| 2023 |
Bailey L, Stone LD, Gonzalez ML, Thomas CM, Jeyarajan H, Warram JM, Panuganti B. Panitumumab-IRDye800 Improves Laryngeal Tumor Mapping During Transoral Laser Microsurgery. The Laryngoscope. PMID 37860983 DOI: 10.1002/lary.31078 |
0.324 |
|
| 2022 |
Stone LD, Massicano AVF, Stevens TM, Warram JM, Morlandt AB, Lapi SE, Amm HM. Zr-panitumumab PET imaging for preoperative assessment of ameloblastoma in a PDX model. Scientific Reports. 12: 19187. PMID 36357495 DOI: 10.1038/s41598-022-23531-z |
0.338 |
|
| 2020 |
Warram JM, Napier TS, Udayakumar N, Jani AH, Hartman YE, Houson HA, Moore L, Amm HM, van den Berg NS, Sorace AG. Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme. Molecular Cancer Therapeutics. PMID 32606015 DOI: 10.1158/1535-7163.Mct-19-0819 |
0.407 |
|
| 2020 |
Morlandt AB, Moore LS, Johnson AO, Smith CM, Stevens TM, Warram JM, MacDougall M, Rosenthal EL, Amm HM. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. PMID 32554066 DOI: 10.1016/J.Joms.2020.05.022 |
0.419 |
|
| 2019 |
Kasten BB, Jiang K, Cole D, Jani A, Udayakumar N, Gillespie GY, Lu G, Dai T, Rosenthal EL, Markert JM, Rao J, Warram JM. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31773232 DOI: 10.1007/S00259-019-04607-X |
0.336 |
|
| 2019 |
Kasten BB, Udayakumar N, Leavenworth JW, Wu AM, Lapi SE, McConathy JE, Sorace AG, Bag AK, Markert JM, Warram JM. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics. 9: 5085-5104. PMID 31410203 DOI: 10.7150/Thno.34415 |
0.398 |
|
| 2019 |
Gentile CM, Borovjagin AV, Richter JR, Jani AH, Wu H, Zinn KR, Warram JM. Genetic strategy to decrease complement activation with adenoviral therapies. Plos One. 14: e0215226. PMID 31026285 DOI: 10.1371/Journal.Pone.0215226 |
0.511 |
|
| 2019 |
Gambhir SS, Shankar LK, Rosenthal E, Warram JM, Ghesani MV, Hope TA, Jacobs PM, Jacobson GB, Wilson T, Siegel BA. Proceedings - Pathways for Successful Translation of New Imaging Agents and Modalities: Phase III Studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30850482 DOI: 10.2967/Jnumed.118.219824 |
0.419 |
|
| 2019 |
Marston JC, Kennedy GD, Lapi SE, Hartman YE, Richardson MT, Modi HM, Warram JM. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer. The Journal of Surgical Research. 239: 44-51. PMID 30798171 DOI: 10.1016/J.Jss.2019.01.065 |
0.385 |
|
| 2019 |
Walsh EM, Cole D, Tipirneni KE, Bland KI, Udayakumar N, Kasten BB, Bevans SL, McGrew BM, Kain JJ, Nguyen QT, Rosenthal EL, Warram JM. Fluorescence Imaging of Nerves During Surgery. Annals of Surgery. PMID 30649014 DOI: 10.1097/Sla.0000000000003130 |
0.335 |
|
| 2018 |
Tummers WS, Warram JM, van den Berg NS, Miller SE, Swijnenburg RJ, Vahrmeijer AL, Rosenthal EL. Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics. 8: 5336-5347. PMID 30555550 DOI: 10.7150/Thno.27384 |
0.402 |
|
| 2018 |
Prince AC, Patel NG, Moore LS, McGee AS, Ahn JC, Willey CD, Carroll WR, Rosenthal EL, Warram JM. Adjuvant Anti-angiogenic Therapy Enhances Chemotherapeutic Uptake in a Murine Model of Head and Neck Cancer. Journal of Drug Targeting. 1-25. PMID 29972342 DOI: 10.1080/1061186X.2018.1497040 |
0.311 |
|
| 2018 |
Gao RW, Teraphongphom NT, van den Berg NS, Martin BA, Oberhelman NJ, Divi V, Kaplan MJ, Hong SS, Lu G, Ertsey R, Tummers WS, Gomez AJ, Holsinger FC, Kong CS, Colevas AD, ... Warram JM, et al. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence. Cancer Research. PMID 29967260 DOI: 10.1158/0008-5472.Can-18-0878 |
0.469 |
|
| 2018 |
Prince AC, Moore LS, Tipirneni KE, Ramesh T, Limdi MA, Bevans SL, Walsh EM, Greene B, Rosenthal EL, Warram JM. Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer. Surgical Oncology. 27: 225-230. PMID 29937175 DOI: 10.1016/J.Suronc.2018.04.004 |
0.45 |
|
| 2018 |
Gao RW, Teraphongphom N, de Boer E, van den Berg NS, Divi V, Kaplan MJ, Oberhelman NJ, Hong SS, Capes E, Colevas AD, Warram JM, Rosenthal EL. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers. Theranostics. 8: 2488-2495. PMID 29721094 DOI: 10.7150/Thno.24487 |
0.369 |
|
| 2018 |
Marston JC, Hartman YE, Warram JM, Kennedy GD. 855 - Panitumumab-IRDYE800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)34226-4 |
0.349 |
|
| 2017 |
Prince AC, McGee AS, Siegel H, Rosenthal EL, Behnke NK, Warram JM. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma. Journal of Surgical Oncology. PMID 29284070 DOI: 10.1002/Jso.24950 |
0.356 |
|
| 2017 |
Sherwood J, Rich M, Lovas K, Warram J, Bolding MS, Bao Y. T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery. Nanoscale. PMID 28786462 DOI: 10.1039/C7Nr04181K |
0.33 |
|
| 2017 |
Prince AC, Jani A, Korb M, Tipirneni KE, Kasten BB, Rosenthal EL, Warram JM. Characterizing the detection threshold for optical imaging in surgical oncology. Journal of Surgical Oncology. PMID 28628728 DOI: 10.1002/Jso.24733 |
0.414 |
|
| 2017 |
Rosenthal E, Moore L, Tipirneni K, de Boer E, Stevens TM, Hartman YE, Carroll WR, Zinn KR, Warram JM. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28446503 DOI: 10.1158/1078-0432.Ccr-16-2968 |
0.602 |
|
| 2017 |
Tummers WS, Warram JM, Tipirneni KE, Fengler J, Jacobs P, Shankar L, Henderson L, Ballard B, Pogue BW, Weichert JP, Bouvet M, Sorger J, Contag CH, Frangioni JV, Tweedle MF, et al. Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection. Cancer Research. PMID 28428283 DOI: 10.1158/0008-5472.Can-16-3217 |
0.43 |
|
| 2017 |
Tipirneni KE, Rosenthal EL, Moore LS, Haskins AD, Udayakumar N, Jani AH, Carroll WR, Morlandt AB, Bogyo M, Rao J, Warram JM. Fluorescence Imaging for Cancer Screening and Surveillance. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28155079 DOI: 10.1007/S11307-017-1050-5 |
0.404 |
|
| 2017 |
Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, Eliceiri KW, Kuo JS, Weichert JP. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nature Reviews. Clinical Oncology. PMID 28094261 DOI: 10.1038/Nrclinonc.2016.212 |
0.425 |
|
| 2017 |
Behnke NK, Warram JM, Prince AC. Abstract 1870: Fluorescence-guided soft tissue sarcoma surgery using a cetuximab-imaging probe conjugate Cancer Research. 77: 1870-1870. DOI: 10.1158/1538-7445.Am2017-1870 |
0.498 |
|
| 2016 |
Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, et al. Oncologic Procedures Amenable to Fluorescence-guided Surgery. Annals of Surgery. PMID 28045715 DOI: 10.1097/Sla.0000000000002127 |
0.597 |
|
| 2016 |
Moore LS, Rosenthal EL, de Boer E, Prince AC, Patel N, Richman JM, Morlandt AB, Carroll WR, Zinn KR, Warram JM. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27830425 DOI: 10.1007/S11307-016-1022-1 |
0.625 |
|
| 2016 |
Moore LS, Rosenthal EL, Chung TK, de Boer E, Patel N, Prince AC, Korb ML, Walsh EM, Young ES, Stevens TM, Withrow KP, Morlandt AB, Richman J, Carroll WR, Zinn KR, ... Warram JM, et al. Characterizing the utilities and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587708 DOI: 10.2967/Jnumed.115.171413 |
0.598 |
|
| 2016 |
Sweeny L, Prince A, Patel N, Moore LS, Rosenthal EL, Hughley BB, Warram JM. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies. The Laryngoscope. PMID 27576611 DOI: 10.1002/Lary.26215 |
0.333 |
|
| 2016 |
Moore LS, de Boer E, Warram JM, Tucker MD, Carroll WR, Korb ML, Brandwein-Gensler MS, van Dam GM, Rosenthal EL. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models. Cancer Medicine. PMID 27167827 DOI: 10.1002/Cam4.752 |
0.441 |
|
| 2016 |
Kim H, Samuel SL, Lopez-Casas PP, Grizzle WE, Hidalgo M, Kovar J, Oelschlager DK, Zinn KR, Warram JM, Buchsbaum DJ. SPARC independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic cancer xenografts. Molecular Cancer Therapeutics. PMID 26832793 DOI: 10.1158/1535-7163.Mct-15-0764 |
0.607 |
|
| 2016 |
Moore L, Warram JM, Boer Ed, Carroll WR, Morlandt A, Withrow KP, Rosenthal EL. Near-infrared (NIR) fluorescence imaging of head and neck squamous cell carcinoma for fluorescence-guided surgery (Conference Presentation) Proceedings of Spie. 9696: 969610. DOI: 10.1117/12.2214002 |
0.445 |
|
| 2015 |
Korb ML, Warram JM, Grudzinski J, Weichert J, Jeffery J, Rosenthal EL. Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502. Molecular Imaging. 14: 7290201400040. PMID 28654401 DOI: 10.2310/7290.2014.00040 |
0.39 |
|
| 2015 |
Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, et al. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26449839 DOI: 10.2967/Jnumed.115.158915 |
0.594 |
|
| 2015 |
de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26335283 DOI: 10.1007/S11307-015-0892-Y |
0.565 |
|
| 2015 |
de Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, de Jong JS, Chung TK, Korb ML, Zinn KR, van Dam GM, Rosenthal EL, Brandwein-Gensler MS. In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas. Scientific Reports. 5: 10169. PMID 26120042 DOI: 10.1038/Srep10169 |
0.617 |
|
| 2015 |
Warram JM, de Boer E, Moore LS, Schmalbach CE, Withrow KP, Carroll WR, Richman JS, Morlandt AB, Brandwein-Gensler M, Rosenthal EL. A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery. Journal of Surgical Oncology. PMID 26074273 DOI: 10.1002/Jso.23946 |
0.409 |
|
| 2015 |
Warram JM, de Boer E, Korb M, Hartman Y, Kovar J, Markert JM, Gillespie GY, Rosenthal EL. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. British Journal of Neurosurgery. 1-9. PMID 26073144 DOI: 10.3109/02688697.2015.1056090 |
0.432 |
|
| 2015 |
Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, Strong TV, Schmalbach C, Morlandt A, Agarwal G, Hartman YE, Carroll W, Richman JS, Clemons L, Nabell LM, et al. Safety and Tumor-specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25904751 DOI: 10.1158/1078-0432.Ccr-14-3284 |
0.595 |
|
| 2015 |
de Boer E, Moore LS, Warram JM, Huang CC, Brandwein-Gensler MS, van Dam GM, Rosenthal EL, Schmalbach CE. On the horizon: Optical imaging for cutaneous squamous cell carcinoma. Head & Neck. PMID 25899874 DOI: 10.1002/Hed.24079 |
0.357 |
|
| 2015 |
Chung TK, Warram J, Day KE, Hartman Y, Rosenthal EL. Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies. Cancer Biology & Therapy. 16: 790-8. PMID 25719497 DOI: 10.1080/15384047.2015.1016664 |
0.436 |
|
| 2015 |
Rosenthal EL, Warram JM, Bland KI, Zinn KR. The status of contemporary image-guided modalities in oncologic surgery. Annals of Surgery. 261: 46-55. PMID 25599326 DOI: 10.1097/Sla.0000000000000622 |
0.566 |
|
| 2015 |
Zinn KR, Korb M, Samuel S, Warram JM, Dion D, Killingsworth C, Fan J, Schoeb T, Strong TV, Rosenthal EL. IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 49-57. PMID 25080323 DOI: 10.1007/S11307-014-0773-9 |
0.586 |
|
| 2015 |
Rosenthal EL, Boer Ed, Zinn K, Dam Gv, Warram J. Abstract SY36-02: Visualizing cancer: Surgical navigation using targeted fluorescent imaging agents Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Sy36-02 |
0.678 |
|
| 2015 |
Korb M, Boone J, Warram J, Chung T, Bland K, Rosenthal E, Huh W. Fluorescent illumination of the genitourinary tract in laparoscopic surgery: A novel in vivo imaging technique Gynecologic Oncology. 137: 130-131. DOI: 10.1016/J.Ygyno.2015.01.324 |
0.356 |
|
| 2015 |
de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques Molecular Imaging and Biology. DOI: 10.1007/s11307-015-0892-y |
0.459 |
|
| 2014 |
Korb ML, Warram JM, Grudzinski J, Weichert J, Jeffery J, Rosenthal EL. Breast cancer imaging using the near-infrared fluorescent agent, CLR1502. Molecular Imaging. 13. PMID 25743270 DOI: 10.2310/7290.2014.00040 |
0.487 |
|
| 2014 |
de Boer E, Warram JM, Hartmans E, Bremer PJ, Bijl B, Crane LM, Nagengast WB, Rosenthal EL, van Dam GM. A standardized light-emitting diode device for photoimmunotherapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1893-8. PMID 25315245 DOI: 10.2967/Jnumed.114.142299 |
0.337 |
|
| 2014 |
Richter JR, Mahoney M, Warram JM, Samuel S, Zinn KR. A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging. Gene Therapy. 21: 897-902. PMID 25056609 DOI: 10.1038/Gt.2014.68 |
0.587 |
|
| 2014 |
Warram JM, de Boer E, Sorace AG, Chung TK, Kim H, Pleijhuis RG, van Dam GM, Rosenthal EL. Antibody-based imaging strategies for cancer. Cancer Metastasis Reviews. 33: 809-22. PMID 24913898 DOI: 10.1007/S10555-014-9505-5 |
0.433 |
|
| 2014 |
Warram JM, Sorace AG, Mahoney M, Samuel S, Harbin B, Joshi M, Martin A, Whitworth L, Hoyt K, Zinn KR. Biodistribution of P-selectin targeted microbubbles. Journal of Drug Targeting. 22: 387-94. PMID 24731055 DOI: 10.3109/1061186X.2013.869822 |
0.598 |
|
| 2014 |
Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K. Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound in Medicine & Biology. 40: 755-64. PMID 24412168 DOI: 10.1016/J.Ultrasmedbio.2013.11.002 |
0.609 |
|
| 2014 |
Foster RC, Krell AM, Chung TK, Warram JM, Zinn KR, Rosenthal EL. Characterizing fluorescent imaging properties of antibodies conjugated to IRDye800CW for use in imaging of head and neck cancer Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8926. DOI: 10.1117/12.2044435 |
0.597 |
|
| 2014 |
Korb ML, Warram JM, Warren ME, Samuel SL, Zinn KR, Bland KI, Rosenthal EL. Defining the Detection Threshold for Optical Imaging in Surgical Resection Journal of the American College of Surgeons. 219: S128. DOI: 10.1016/J.Jamcollsurg.2014.07.305 |
0.554 |
|
| 2013 |
Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound in Medicine & Biology. 39: 2374-81. PMID 24063960 DOI: 10.1016/J.Ultrasmedbio.2013.07.017 |
0.589 |
|
| 2013 |
Sorace AG, Saini R, Rosenthal E, Warram JM, Zinn KR, Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 60: 281-9. PMID 23357902 DOI: 10.1109/Tuffc.2013.2564 |
0.66 |
|
| 2013 |
Saini R, Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K. An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound in Medicine & Biology. 39: 172-80. PMID 23122640 DOI: 10.1016/J.Ultrasmedbio.2012.08.016 |
0.619 |
|
| 2012 |
Knowles JA, Heath CH, Saini R, Umphrey H, Warram J, Hoyt K, Rosenthal EL. Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 138: 662-8. PMID 22801891 DOI: 10.1001/Archoto.2012.1081 |
0.367 |
|
| 2012 |
Warram JM, Sorace AG, Saini R, Borovjagin AV, Hoyt K, Zinn KR. Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Therapy. 19: 545-52. PMID 22653385 DOI: 10.1038/Cgt.2012.29 |
0.586 |
|
| 2012 |
Sorace AG, Warram JM, Umphrey H, Hoyt K. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. Journal of Drug Targeting. 20: 43-54. PMID 21981609 DOI: 10.3109/1061186X.2011.622397 |
0.335 |
|
| 2012 |
Sorace AG, Saini R, Mahoney M, Warram JM, Zinn KR, Hoyt K. Molecular ultrasound imaging using a novel tumor-bearing animal model with variable target receptor expression Ieee International Ultrasonics Symposium, Ius. 2049-2051. DOI: 10.1109/ULTSYM.2012.0512 |
0.573 |
|
| 2011 |
Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 30: 921-31. PMID 21705725 DOI: 10.7863/Jum.2011.30.7.921 |
0.595 |
|
| 2011 |
Saini R, Warram JM, Sorace AG, Umphrey H, Zinn KR, Hoyt K. Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound in Medicine & Biology. 37: 1306-13. PMID 21683507 DOI: 10.1016/J.Ultrasmedbio.2011.05.010 |
0.577 |
|
| 2011 |
Liu Z, Hartman YE, Warram JM, Knowles JA, Sweeny L, Zhou T, Rosenthal EL. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Molecular Cancer Research : McR. 9: 1008-17. PMID 21665938 DOI: 10.1158/1541-7786.Mcr-11-0043 |
0.361 |
|
| 2011 |
Warram JM, Borovjagin AV, Zinn KR. A genetic strategy for combined screening and localized imaging of breast cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 452-61. PMID 20658194 DOI: 10.1007/S11307-010-0377-Y |
0.616 |
|
| 2010 |
Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, Zinn KR. Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 29: 577-85. PMID 20375376 DOI: 10.7863/Jum.2010.29.4.577 |
0.563 |
|
| 2010 |
Saini R, Warram J, Sorace AG, Umphrey H, Zinn KR, Hoyt K. Validation of controlled receptor expression using adenoviral techniquesand targeted ultrasound imaging Proceedings - Ieee Ultrasonics Symposium. 1125-1128. DOI: 10.1109/ULTSYM.2010.5935763 |
0.53 |
|
| 2009 |
Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis. Cancer Biology & Therapy. 8: 1109-16. PMID 19652526 DOI: 10.4161/Cbt.8.12.8327 |
0.717 |
|
| 2009 |
Hoyt K, Warram JM, Umphrey H, Belt L, Samuel S, Folks K, Stockard C, Lockhart M, Robbin ML, Grizzle W, Zinn KR. Assessing breast cancer response to bevacizumab using contrast-enhanced ultrasound: Initial results using a murine model Proceedings - Ieee Ultrasonics Symposium. DOI: 10.1109/ULTSYM.2009.5441595 |
0.531 |
|
| 2008 |
Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Research. 68: 8369-76. PMID 18922909 DOI: 10.1158/0008-5472.Can-08-1771 |
0.611 |
|
| 2008 |
Kim H, Morgan DE, Zeng H, Grizzle WE, Warram JM, Stockard CR, Wang D, Zinn KR. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology. 248: 844-51. PMID 18710978 DOI: 10.1148/Radiol.2483071740 |
0.599 |
|
| 2008 |
Wang X, Jiang J, Warram J, Baumann G, Gan Y, Menon RK, Denson LA, Zinn KR, Frank SJ. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Molecular Endocrinology (Baltimore, Md.). 22: 1427-37. PMID 18323468 DOI: 10.1210/Me.2007-0561 |
0.52 |
|
| Show low-probability matches. |